Stable Isotope Labeled Compounds Market Expected to Grow at 312 Million In Revenue by 2024
According to Market Study Report, Stable Isotope Labeled Compounds Market provides a comprehensive analysis of the Stable Isotope Labeled Compounds market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. This report also provides market landscape and market share information in the Stable Isotope Labeled Compounds market.
Get Free Sample Report in PDF Format @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=1140027
The Global Stable Isotope Labeled Compounds Market size is projected to reach US$ 312 Million by 2024 from US$ 269 Million in 2019, at a CAGR of 3.0%. This report spread across 135 Pages, Profiling 20 Companies and Supported with 118 Tables and 21 figures are now available in this research.
Top Key Players profiled in the Stable Isotope Labeled Compounds Market:
PerkinElmer Inc. (US)
Merck KGaA (Germany)
Cambridge Isotope Laboratories Inc. (US)
URENCO Limited (UK)
Medical Isotopes Inc. (US)
Omicron Biochemicals Inc. (US)
Trace Sciences International (US)
Taiyo Nippon Sanso Corporation (Japan)
Rotem Industries Israel Ltd. (Israel)
“By type, the H-2 labeled compounds segment is expected to grow at the highest CAGR during the forecast period.”
Based on component, the stable isotope-labeled compounds market is segmented into C-13, N-15, O-18, H-2 (deuterium), and other isotopes. The H-2 labeled compounds segment accounted for the largest market share in 2018. This segment is also expected to register the highest growth during the forecast period. This growth in this segment is driven primarily by growing drug research in the pharmaceutical industry and the increasing availability of deuterium-labeled compounds.
Coupon Code Available for 20% Discount @ https://www.reportsnreports.com/purchase.aspx?name=1140027
“By application, the research segment dominated the stable isotope labeled compounds market in 2018.”
Based on technology, the stable isotope-labeled compounds market is segmented into research, clinical diagnostics, industrial applications, and other applications. The research segment accounted for the largest share of the stable isotope-labeled compounds market in 2018, owing to rising research activities in the biomedical, pharmaceutical, environmental & ecological, and agricultural sectors.
“North America stable isotope labeled compounds market is expected to witness the highest growth during the forecast period.”
The North America region market is estimated to grow at the highest CAGR during the forecast period, primarily due to the growing pharmaceutical and biopharmaceutical industry, support from the Isotope Production and Distribution Program Fund, and the presence of a large nuclear industry are driving market growth in the region.
Competitive Landscape of Stable Isotope Labeled Compounds Market:
2 Market Share Analysis, 2018
3 Competitive Scenario
4 Competitive Leadership Mapping (Overall Market) (2018)
4.1 Visionary Leaders
4.3 Dynamic Differentiators
4.4 Emerging Companies
Reason to access this report:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the stable isotope labeled compounds market
Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the stable isotope labeled compounds market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new systems, growing geographies, and recent developments in the global stable isotope labeled compounds market
Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and services of the leading players in the stable isotope labeled compounds market